ProGnosis Biotech participated once again in the AOAC (Association of Official Analytical Collaboration) INTERNATIONAL Annual Meeting & Exposition 2025, held from August 23 to 28 at the Town and Country Resort in San Diego, California. The event served as a key forum for collaboration between laboratories, regulatory bodies and industry leaders dedicated to developing and validating methods that ensure food quality, safety and compliance on a global scale.
ProGnosis Biotech presented a comprehensive range of rapid diagnostic solutions featuring mycotoxin and allergen detection kits, ATP hygiene monitoring systems and an Android mobile application enabling on-site testing, instant result sharing and seamless data integration.
The scientific program wan enriched by three innovative poster presentations by ProGnosis Biotech’s R&D team:
1. “An Innovative and Rapid Lateral Flow Assay for the Quantification of T2 and HT2 in Grains and Cereals. Detection of T2HT2-Free Samples in Just 2 Minutes.”
2. “Validation of a common extraction protocol for the detection and quantification of milk proteins using lateral flow tests.”
3. “Validation of a 60-Minute Quantitative ELISA for Tenuazonic Acid Determination in Tomatoes, Cereals, Sunflower-Based Products and Fruit Juices Using an In-House Monoclonal Antibody.”
Throughout the six-day conference, the ProGnosis Biotech team engaged with analytical professionals to exchange insights on method validations and quality assurance. The company’s participation at AOAC 2025 reaffirmed its commitment to scientific advancement and provided new perspectives into food safety. Knowledge is the driving force behind innovation, and events like these, where industry experts come together to exchange ideas, pave the way for higher-quality products and a more transparent, safer food market.
